Great news so why are we down from 3 to 1? Down over 67% from high to low in 1 year
We need to triple to break even. I’m hanging in there. Many of my small biotechs are in the same boat.
Great products, great news, great potential but no income.
RDHL has revenues but still goes down
ATHX, CAPR, PSTI, TNXP & SRNE all have potential to triple or more.
All have had good runs and come back down. I’m betting that at least 3 of these 6 will do it again in 2022.
Be patient, good luck and happy new year to all!,
News 
Market Data 
Discover 
